Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05567744

Registry for CADASIL

Research Registry for Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,500 (estimated)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invited to participate in future research studies on CADASIL. Participants must be 18 years or older, and will remain on the registry until they request to be removed.

Detailed description

The purpose of this registry is to allow Dr. Jane Paulsen and her CADASIL research teams to contact individuals on the list who may fit a study's eligibility requirements. All individuals interested in CADASIL research who either have a family member or loved one, or are at risk themselves, are eligible to participate in this registry. Information collected as part of the registry will be used solely to determine potential participant's eligibility to participate research. A patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose(s).

Conditions

Interventions

TypeNameDescription
OTHERRegistryRegistry

Timeline

Start date
2022-06-03
Primary completion
2027-10-01
Completion
2027-10-01
First posted
2022-10-05
Last updated
2025-10-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05567744. Inclusion in this directory is not an endorsement.